Medical Devices
-
Mario Tama via Getty Images
Judge orders J&J to pay Auris investors more than $1B for merger violations
Johnson & Johnson did not provide Auris Health with resources to achieve regulatory milestones after acquiring the robotics company in 2019, the judge found.
By Ricky Zipp • Sept. 6, 2024 -
Courtesy of Abbott
Abbott debuts Lingo over-the-counter CGM in the US
Priced at $49 for one 14-day sensor, or $89 per month, Abbott’s offering is competitive with Dexcom’s Stelo sensor.
By Elise Reuter • Sept. 6, 2024 -
Explore the Trendlineâž”
Sitthiphong via Getty Images
TrendlineMedical device industry continues to turn to AI
While the industry continues to embrace artificial intelligence, there are still questions about how the new technologies need to be regulated and if they are effective.
By MedTech Dive staff -
Permission granted by Abbott Laboratories
Abbott partners with maker of ‘bionic pancreas’
Abbott will integrate its latest glucose sensor with Beta Bionics’ automated insulin delivery system.
By Nick Paul Taylor • Sept. 5, 2024 -
Retrieved from The Food and Drug Administration.
FDA cracks down on ozone cleaners for CPAP machines
The agency sent warning letters to four companies and reminded the public it has not authorized any devices for cleaning or disinfecting CPAPs.
By Elise Reuter • Sept. 5, 2024 -
Courtesy of Edwards Lifesciences
Edwards cuts more than 500 employees after critical care sale
An Edwards spokesperson said the layoffs, affecting 3% of its workforce, are a “one-time right-sizing” deemed necessary following the division’s sale to BD.
By Susan Kelly • Sept. 5, 2024 -
Courtesy of Insightec
Medtech venture investment recovery continues, but startup M&A remains limited: Pitchbook
Acquisitions of late-stage VC startups have been rare, a fact Pitchbook attributed to “ongoing price gaps between buyers and sellers.”
By Nick Paul Taylor • Sept. 4, 2024 -
SDI Productions via Getty Images
European heart group recommends renal denervation for some patients
The European Society of Cardiology said the treatment may be considered for certain patients with uncontrolled, drug-resistant high blood pressure but outlined lingering concerns.
By Nick Paul Taylor • Sept. 4, 2024 -
Permission granted by Nasdaq
Embecta gets FDA nod for insulin patch pump
Embecta’s first patch pump features a larger insulin reservoir, based on feedback from people with Type 2 diabetes.
By Elise Reuter • Sept. 3, 2024 -
Courtesy of Grail
Illumina avoids fine for Grail purchase in European court victory
Illumina will avoid a penalty of 432 million euros after a court ruled the European Commission did not have jurisdiction to challenge the company’s Grail acquisition.
By Susan Kelly • Sept. 3, 2024 -
Permission granted by Medtronic
Medtronic’s chief medical officer of acute care and monitoring departs for new role
Sam Ajizian leaves Medtronic six months after the company reversed a plan to split off its patient monitoring business.
By Nick Paul Taylor • Aug. 30, 2024 -
Sarah Silbiger via Getty Images
FDA finalizes Voluntary Malfunction Summary Reporting guidance
The agency clarified when companies can submit device malfunction reports in a quarterly summary, instead of individual reports every 30 days.
By Nick Paul Taylor • Aug. 30, 2024 -
Courtesy of Penumbra
Penumbra axes virtual reality division, will lay off 71 people
CEO Adam Elsesser told investors the company’s focus needs to be on its core thrombectomy business as it cut its sales forecast for 2024.
By Elise Reuter • Aug. 29, 2024 -
Rob Carr / Staff via Getty Images
Johns Hopkins, CareFirst, Techstars launch healthcare AI accelerator
The 13-week program will offer funding and guidance to up to 12 health tech, medtech and biotech startups working on AI tools.
By Emily Olsen • Aug. 29, 2024 -
Courtesy of Boston Scientific
Boston Scientific receives CE mark for updated TAVR technology
Changes include the addition of a larger valve size that company executives have said will open up 25% of the market in Europe.
By Nick Paul Taylor • Aug. 28, 2024 -
Retrieved from UFP Technologies on August 27, 2024
UFPÂ to buy device component maker AQF Medical, extending deal spree
AQF makes foam and thermoplastic components for use in medical devices and packaging.
By Nick Paul Taylor • Aug. 28, 2024 -
Permission granted by Insulet
Q&AInsulet’s Trang Ly on overcoming ‘clinical inertia’ in diabetes care
Automated insulin delivery for Type 2 patients can help change minds among physicians who have been reluctant to prescribe pump therapy, the chief medical officer said in an interview.
By Susan Kelly • Aug. 27, 2024 -
Kahan Shan via Getty Images
Inari updates label of clot removal device linked to 6 deaths
Inari recalled the catheter and revised instructions for use after reports of the device becoming entrapped or blocking patients’ lung arteries.
By Nick Paul Taylor • Aug. 27, 2024 -
Courtesy of Siemens Healthineers
Siemens Healthineers to grow PET imaging with purchase of Novartis assets
Siemens will pay 200 million euros for the manufacturing and distribution network of Novartis’ radiopharmaceutical molecular imaging business.
By Nick Paul Taylor • Aug. 27, 2024 -
Courtesy of Insulet
Insulet expands Omnipod 5 pump to people with Type 2 diabetes
The FDA clearance marks the first automated insulin delivery system for people with Type 2 diabetes.
By Elise Reuter • Aug. 26, 2024 -
Courtesy of Dexcom
Dexcom prices first over-the-counter glucose monitor
Known as Stelo, the device is intended for people who don’t take insulin and costs $89 per month.
By Elise Reuter • Aug. 26, 2024 -
Sarah Silbiger via Getty Images
Defibtech recalls chest compression device linked to patient death
Customers are asked to return affected devices due to a problem in the motor that could stop compressions.
By Nick Paul Taylor • Aug. 26, 2024 -
Sarah Silbiger via Getty Images
FDA seeks feedback on predetermined change control plans
The guidance describes changes companies can make to medical devices without filing a new 510(k) or premarket approval supplement.
By Nick Paul Taylor • Aug. 26, 2024 -
Retrieved from Stryker on August 23, 2024
Stryker to add back pain treatment with Vertos Medical buy
Stryker’s latest purchase comes amid a pickup in medtech M&A, with Johnson & Johnson, Boston Scientific and Edwards Lifesciences all active this year.
By Susan Kelly • Aug. 23, 2024 -
Courtesy of Procept Biorobotics
Procept wins FDA clearance for updated prostate surgery robot
Procept Biorobotics has added AI capabilities and switched to a single-use scope to support mass-market adoption.
By Nick Paul Taylor • Aug. 22, 2024 -
Avosb via Getty Images
Zoll to buy Vyaire’s ventilator business with $37M auction bid
Vyaire Medical held a virtual auction of assets after filing for Chapter 11 bankruptcy protection in June.
By Nick Paul Taylor • Aug. 21, 2024
